Expression of COL6A1 in Tumor Matrix of Cholangiocarcinoma and Its Mechanism of Tumor Progression
Cancer Reports · 2026
DOI: 10.1002/cnr2.70716 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Reports, 2026. Verfasst von Weibin Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Jinzhou Central Hospital, Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Collagen Type VI, Bile Duct Neoplasms, Extracellular Matrix. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Background
Cholangiocarcinoma (CCA), a malignant tumor originating from the bile duct epithelial cells, is characterized by aggressive invasion and poor prognosis. Abnormal remodeling of the tumor microenvironment plays a pivotal role in its disease progression. The tumor stroma, which is a core component of the tumor microenvironment, comprises an extracellular matrix and various stromal cells. Changes in its composition are closely associated with tumor proliferation, invasion, metastasis, and drug resistance. Collagen Type VI alpha 1 chain (COL6A1), an important functional protein in the extracellular matrix, plays a carcinogenic role in multiple malignant tumors; it participates in matrix remodeling and cellular signaling and influences the tumor immune microenvironment. This systematic review aims to examine the biological properties of COL6A1 and the structural characteristics of CCA tumor stroma, and summarize the roles of stromal COL6A1 in CCA. Recent Findings We outline the expression patterns of stromal COL6A1 in CCA and its correlation with clinicopathological features. Specifically, we systematically discuss the molecular mechanisms by which COL6A1 facilitates CCA progression, including mediating stromal remodeling, cancer‐associated fibroblast activation, oncogenic signaling cascades, the immunosuppressive microenvironment, and therapeutic resistance. COL6A1 shows translational potential as a diagnostic biomarker, staging indicator, and prognostic predictor for CCA.
Conclusion
COL6A1 is a critical molecule regulating stromal remodeling and malignant progression of CCA. This review highlights the current research gaps and proposes prospective research directions, providing a theoretical foundation for future investigations and clinical translations using COL6A1 in CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jinzhou Central Hospital, Jinzhou, Liaoning, China.
- Graduate School, Jinzhou Medical University Postgraduate Training Base (Jinzhou Central Hospital), Jinzhou, Liaoning, China.
- Department of Radiology, Jinzhou Maternal and Infant Hospital, Jinzhou, Liaoning, China.
ORCID-Profile: Weibin Zhang, Chongshi Gao, Chongzhou Lan, Jia Dong, Boxing Xu, Yingmei Li, Jin Dai, Baitong Che, Cheng Li, Gang Dong, Yunfei Wu, Bo Li, Cheng Yang, Lingmei Kong
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Zhang, W., Gao, C., Lan, C., Dong, J., Xu, B., Li, Y., Dai, J., Che, B., Li, C., Dong, G., Wu, Y., Li, B., Yang, C., & Kong, L. (2026). Expression of COL6A1 in Tumor Matrix of Cholangiocarcinoma and Its Mechanism of Tumor Progression. Cancer Reports. https://doi.org/10.1002/cnr2.70716
Vancouver
Zhang W, Gao C, Lan C, Dong J, Xu B, Li Y, et al. Expression of COL6A1 in Tumor Matrix of Cholangiocarcinoma and Its Mechanism of Tumor Progression. Cancer Reports. 2026. doi:10.1002/cnr2.70716
BibTeX
@article{Zhang2026,
author = {Zhang, Weibin and Gao, Chongshi and Lan, Chongzhou and Dong, Jia and Xu, Boxing and Li, Yingmei and Dai, Jin and Che, Baitong and Li, Cheng and Dong, Gang and Wu, Yunfei and Li, Bo and Yang, Cheng and Kong, Lingmei},
title = {Expression of COL6A1 in Tumor Matrix of Cholangiocarcinoma and Its Mechanism of Tumor Progression},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70716}
}
EUVIMED